AGAlden L. Gross

Alden L. Gross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alden L. Gross has a total of 437 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Measuring Structural Intersectionality Through State Policy Contexts: Development of a Policy-Based State Discrimination (PBSD) Measure

    by Sara Daniel, Lorraine T. Dean, Alden Gross, Rashelle Musci, Bryan Lau

    Few existing measures of structural discrimination consider the synergistic effects of racism, sexism, and classism on health inequities. Using intersectionality as an analytical tool, we developed a policy-based state discrimination measure. From an initial pool of 235 policies, we selected 87 thematically relevant policies across various domains as potential indicators of intersectional structural discrimination. We conducted a series of confirmatory factor analyses (CFA) to evaluate the relationship between our policy domains and the underlying latent constructs of racism, sexism, and classism. We identified two models to quantify intersectional state-level discrimination. A 3-factor model for racism, sexism, and classism included 9 policy domains and showed good fit (RMSEA: 0.026; CFI: 0.989; TLI: 0.983). A unidimensional model for intersectional discrimination also included 9 policy domains and showed good fit (RMSEA: 0.014; CFI: 0.996; TLI: 0.995). Top policy drivers of intersectional structural discrimination were domains related to the social safety net, criminal justice, and sexual and reproductive health. This measure of state-level structural discrimination advances our understanding of the intersecting effects of structural racism, sexism, and classism on health inequities by quantifying the combined effects of multiple policies and can be used to account for the policy context of each state.

  • Open Access

    Sex-Specific Machine Learning–Enabled Risk Prediction for Dementia Using Cardiovascular Risk Factors

    by Jingzhi Yu, John Stephen, Lucia C. Petito, Abigail Gauen, Lihui Zhao, Maxwell Mansolf, Elizabeth A. Peterson, Rachel Zmora, Denise Scholtens, Katherine Giorgio, et al.

    Background and ObjectivesDementia remains without curative treatments, underscoring the need for early identification of high-risk individuals. There may be sex-specific differences in associations...

  • Open Access

    The Association Between APOE Genotype, Race, and Dementia

    by Natalia Lakomski, Katherine Giorgio, John Stephen, Maxwell Mansolf, Aïcha Soumaré, Alden L. Gross, Allison E. Aiello, Archana Singh-Manoux, M. Arfan Ikram, Catherine Helmer, et al.

    Background and ObjectivesThe apolipoprotein E (APOE) haplotypes are known to be associated with dementia, with the ε4 haplotype associated with higher risk. It has been suggested that the APOE ε2 a...


  • Frailty as a Modifier of the Associations Between Vascular Risk Factors and Incident Dementia

    by Jason R. Smith, A. Richey Sharrett, James Russell Pike, Rebecca F. Gottesman, David S. Knopman, B. Gwen Windham, Pamela L. Lutsey, Priya Palta, Josef Coresh, Karen Bandeen-Roche, et al.

    The contribution of late-life vascular risk factors to dementia risk remains controversial. Because low blood pressure (BP) has been associated with worse clinical outcomes in frail individuals, we hypothesized hypertension, but not diabetes or smoking, is associated with higher dementia risk in robust than in frail older adults. We performed a prospective cohort analysis of the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS) over 11 years (2011-2022). We included all community-living White and Black participants aged 67-89 years without dementia at baseline visit 5 (2011-2013) from ARIC-NCS field centers (Jackson, Mississippi; Forsyth County, North Carolina; Washington County, Maryland; Minneapolis suburbs, Minnesota). The primary vascular risk factors measured at baseline included elevated BP (systolic BP 120-129 mm Hg and diastolic BP < 80 mm Hg), hypertension (systolic BP ≥ 130 mm Hg, diastolic BP ≥ 80 mm Hg, or use of medication for BP), diabetes (fasting glucose ≥126 mg/dL, nonfasting glucose ≥200 mg/dL, self-reported physician's diagnosis, or use of diabetes medication), and former and current smoking (self-reported). We defined frailty status using the Fried criteria (5 components that include low energy, low physical activity, slowness, weakness, and weight loss). We estimated cause-specific hazard ratios (HRs) of incident dementia (ascertained from in-person neuropsychological assessments, semiannual participant or informant report, or surveillance of claims from hospitalizations and death certificates) with Cox proportional hazards models including a multiplicative interaction between vascular factors and frailty. HRs of dementia were then stratified by frailty (robust [no frailty components present] vs prefrail/frail [at least 1 frailty component present]). There were 377 (15.8%) dementia cases in robust participants (n = 2,383; mean age, 74.2 years; 55.4% female) and 812 (30.0%) in prefrail/frail participants (n = 2,710; mean age 76.4 years; 61.3% female). There was a significant interaction between BP and frailty on dementia risk (p = 0.026). For robust participants, HRs were 1.03 (95% CI 0.65-1.64) for elevated BP and 1.39 (95% CI 1.00-1.94) for hypertension relative to normal BP. For prefrail/frail participants, HRs were 0.68 (95% CI 0.49-0.95) and 0.82 (95% CI 0.66-1.01), respectively. Diabetes and current smoking were associated with higher dementia risk in both robust and prefrail/frail individuals. Late-life hypertension was associated with a lower relative risk of dementia in prefrail/frail participants, but the association was positive in robust participants. BP interpretation and management to support brain health in older adults could consider age-related functional status.


  • Open Access

    Risk and protective factors for cognitive decline in older adults from a nationally representative sample in India: Results from the LASI‐DAD

    by Alden L. Gross, Emma Nichols, Miguel Arce Rentería, Pranali Y. Khobragade, Erik Meijer, Sarah Petrosyan, Mathew Varghese, Albert Weerman, Peifeng Hu, Joyita Banerjee, et al.

    INTRODUCTION: We characterized modifiable risk and protective factors for cognitive decline in India. METHODS: Using the first nationally representative population‐based longitudinal sample of N = 6168 older adults in India, we evaluated associations of risk factors (demographic characteristics, self‐reported and objective health characteristics, health behaviors, and sensory function) for late‐life cognitive decline with up to 6.4 years of follow‐up (range: 2.8 to 6.4 years). RESULTS: The mean rate of general cognitive decline was −0.029 SD per year and was progressively steeper with age. Most risk factors, particularly demographic and cardiovascular characteristics, were associated with steeper cognitive decline in expected directions: Associations of history of high cholesterol or heart attack on rate of cognitive decline, for example, were comparable to being 8 to 10 years older. DISCUSSION: Most risk factors were associated with change in expected directions, highlighting the potential generalizability to India of previously identified risk factors for dementia.


  • Association of Pre-stroke Cardiovascular Risk With Post-stroke Cognitive Decline and Dementia

    by Deborah A. Levine, Wan-Ling Hsu, Wen Ye, Rachael Torres Whitney, Jeremy B. Sussman, Emily M. Briceño, Alden L. Gross, Bruno J. Giordani, Ronald M. Lazar, Virginia J. Howard, et al.

  • Contingency of Plasma Dementia Biomarkers on Cognitive Profiles for Prognosis of Incident Dementia

    by David S. Knopman, James Russell Pike, Michael Griswold, Yifei Lu, Alden Gross, Thomas H. Mosley, B. Gwen Windham, Marilyn S. Albert, Keenan A. Walker, Rebecca F. Gottesman, et al.

    Plasma biomarkers such as phospho-tau species are increasingly used in clinical practice for the diagnosis of Alzheimer disease (AD). Phosphorylated-tau at threonine 181 (p-tau181) values also provide prognostic information about incident dementia. Cognitive status similarly conveys prognostic information, but the relationship between plasma biomarkers for AD and cognitive status requires clarification. Participants from the Atherosclerosis Risk in Communities (ARIC) study who were adjudicated as free of dementia in 2011-2013 had plasma samples analyzed for p-tau181 and other biomarkers. Participants were surveilled for incident dementia through December 31, 2022. Cumulative incidence curves, Cox models, and Fine-Gray models were used to evaluate the independent and combined discriminatory accuracy of cognitive status and plasma biomarkers for incident dementia. The sample comprised 1,577 ARIC participants (age 76.5 years, 60% women, 73% White, 27% Black). The risk of incident dementia was higher in persons with a baseline status of mild cognitive impairment (covariate-adjusted hazard ratio [HR] 2.94, 95% CI 2.61-3.33) compared with those who were cognitively unimpaired independent of biomarker status. The risk of dementia was also higher in persons with more abnormal concentrations of p-tau181 and other biomarkers independent of cognitive status. When age, cognitive status, and p-tau181 were included in the same models, the risk was attenuated relative to models where only cognitive status or plasma biomarkers were included. For continuous p-tau181 concentrations, the covariate-adjusted HR without cognitive status was 1.45 (95% CI 1.36-1.54), but when cognitive status was included, the HR decreased to 1.37 (95% CI 1.29-1.46). Models showed that when combined with age, p-tau181 alone, cognitive status alone, or the combination of p-tau181 and cognitive status had similar discriminatory accuracy. Cognitive status and plasma biomarker concentrations convey independent but overlapping information about the risk of incident dementia. Although cognitive status and plasma p-tau181 have similar discriminatory accuracies, the far lower incidence rate of dementia in persons who are initially cognitively unimpaired highlights the importance of an accurate clinical diagnosis.


  • Open Access

    Age at natural menopause and cognitive aging in U.S. women: Educational attainment as a modifiable resilience factor

    by Muqi Guo, Sneha Sarah Mani, Alden L. Gross, Carrie A. Karvonen-Gutierrez, Alexis Reeves, Kenneth M. Langa, Lindsay C. Kobayashi


  • Open Access

    Risk and protective factors of cognitive decline in older adults from a nationally representative sample in India: Results from the LASI‐DAD

    by Alden L. Gross

    Background: Many studies have proposed important risk and protective factors for dementia, although most are from Western samples in high‐income settings, including those summarized in the 2024 Lancet Commission on dementia. Our goal was to characterize modifiable risk factors of cognitive decline in a nationally representative study of older adults in India. Method: We used a detailed neuropsychological battery administered to N = 6,166 community‐living adults aged 60+ years across two waves of the nationally‐representative Harmonized Diagnostic Assessment of Dementia for the Longitudinal Aging Study in India (LASI‐DAD). We established the factor structure of the cognitive battery, derived co‐calibrated measures of cognitive functioning across waves, and evaluated associations of modifiable and non‐modifiable risk factors for late‐life cognitive decline with up to 6.4 years of follow‐up. Risk factors included demographic characteristics, self‐reported and objective health characteristics (i.e., markers of cardiovascular disease), health behaviors, and sensory function. Result: Confirmatory factor analyses to co‐calibrate measures of general cognitive functioning, memory, executive functioning/attention, language/fluency, visuospatial ability, and orientation domains across LASI‐DAD waves 1 and 2 fit well to the data. Most risk factors, particularly demographics and cardiovascular characteristics, were associated with steeper cognitive decline. Conclusion: Most risk factors we evaluated were associated with decline in expected directions, highlighting the potential generalizability of previously identified risk factors for dementia in India. Summary measures of cognitive domains derived in this study can be used in future longitudinal research on cognitive aging in India.


  • Open Access

    Do self-reported and objective hearing measures similarly relate to general and domain-specific cognition? Observational cohort study of older adults in England

    by Brendan Q O’SHea, Rebecca A Milan, Alden L Gross, Danielle S Powell, Lindsay C Kobayashi, Andrew Steptoe

    Objectives: We compared associations between self-reported and HearCheck screening device measures of hearing difficulty with subsequent general and domain-specific cognitive function in a population-based sample of older English adults. Design: Observational cohort study. Setting: Population-based sample of older adults in wave 7 of the English Longitudinal Study of Ageing (ELSA) in 2014/15 and its Healthy Cognitive Ageing Project (HCAP) in 2018. Participants: N=1119 adults aged ≥62 years. Primary outcome measures: Factor scores for general cognitive function and domains of memory, language, orientation and executive function were derived from the HCAP neuropsychological test battery (mean of 0 and SD of 1 for each). Hearing difficulty was assessed using a self-reported 5-point Likert-type scale and the HearCheck screening device, which administered a series of six tones in each ear. Results: According to the HearCheck device, 48% of participants had a mild or moderate-to-severe hearing difficulty, while 25% self-reported fair or poor hearing. In multivariable-adjusted, population-weighted linear regression models, hearing difficulty identified via HearCheck was associated with worse general cognitive function (β=−0.34 SD units; 95% CI −0.60 to –0.07 for moderate-to-severe hearing difficulty vs good hearing) as well as worse function in domains of memory, language and executive function, each with a dose-response relationship. Self-reported hearing difficulty was not associated with general or domain-specific cognitive function. Conclusions: Peripheral hearing ability, as captured by the HearCheck screening device, may have stronger relevance for later-life cognitive outcomes than the broader construct of perceived hearing difficulty in one’s daily environment that is captured by a self-reported measure.